Tanvir Choudhri, MD
img_Tanvir Choudhri
Are you a patient?
Neurosurgery, Spine Surgery
Clinical Trials
CSM-S Trial
National expert member (one of 20). The expert panel evaluates the patients being entered into the trial to establish clinical equipoise. The CSM-S trial is a prospective randomized multicenter trial evaluating clinical and socioeconomic outcome following anterior versus posterior surgical intervention for CSM.

Pfizer STRIVE Trial
Mount Sinai Principal Investigator for STRIVE Trial, a multicenter trial designed to test the efficacy and safety of a vaccine to help prevent infection in people undergoing multi-level spinal fusion surgery.

StemCells Pathway Trial: Mount Sinai
Co-investigator and member of surgical team. The Pathway Trial is designed to test the efficacy and safety of stem cell injection on patients with AIS, A, B, and C chronic spinal cord injury.

InVivo 100-101 Trial: Mount Sinai
Co-investigator on the InVivo 100-101 Trial, which is designed to test the safety of a Scaffold device on patients with complete AIS A acute spinal cord injury.

Vertex VX-210 Trial: Mount Sinai
Co-investigator on the VX-210 Trial, which is designed to test the efficacy and safety of the VX-210 drug on patients with AIS A or B acute spinal cord injury.
Research interests include:

Treatment for chronic (myelopathy) and acute spinal cord injury.

Diagnosis and treatment of repetative neuro-trauma

Development and use of new imaging techniques to improve surgical and nonsurgical treatment of cervical spinal disorders (spinal stenosis, spondylosis, and herniated discs)

Use of minimally-invasive principles/techniques to improve cervical and lumbar spine surgery

Outcomes research to help evaluate and improve current spine surgical procedures.

Spine surgery guidelines development.

Diagnosis of mild traumatic brain injury (mTBI) including concussions and subconcusive injuries.

MD, Columbia University College of Physicians & Surgeons

Internship, Surgery (General Surgery), New York Presbyterian/Columbia Cardiothoracic GME

Residency, Neurosurgery, Columbia University Neurological Surgery

Fellowship, Neurosurgery, Arizona Surgical Hospital


American Board of Neurological Surgery


Top Doctors New York Metro Area

Castle Connolly


Top Doctor

New York Magazine


Schlesinger Fellowship in Neurosurgical Research


Galbraith Award

Congress of Neurological Surgeons


Housestaff Research Award

Columbia-Presbyterian Medical Center


Alpha Omega Alpha


Phi Beta Kappa

Tanvir Choudhri, MD at AANS 2018

Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.

Dr. Choudhri did not report having any of the following types of financial relationships with industry during 2022 and/or 2023: consulting, scientific advisory board, industry-sponsored lectures, service on Board of Directors, participation on industry-sponsored committees, equity ownership valued at greater than 5% of a publicly traded company or any value in a privately held company. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.

Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.